Development of the vaccine received $1.8 billion of American government funds, but it has yet to receive approval in the US, Dado Ruvic / Reuters
Development of the vaccine received $1.8 billion of American government funds, but it has yet to receive approval in the US, Dado Ruvic / Reuters

Novavax Covid-19 vaccine backed by FDA committee




Latest
Most Read
Top Videos

View from DC

The inside scoop from The National’s Washington bureau

      By signing up, I agree to The National's privacy policy
      View from DC